Selective adipocyte loss of Angiopoietin-2 prompts female-specific obesity and metabolic syndrome.


Journal

Molecular metabolism
ISSN: 2212-8778
Titre abrégé: Mol Metab
Pays: Germany
ID NLM: 101605730

Informations de publication

Date de publication:
11 2022
Historique:
received: 06 08 2022
accepted: 26 08 2022
pubmed: 3 9 2022
medline: 12 10 2022
entrez: 2 9 2022
Statut: ppublish

Résumé

Thermogenic fat differentiation and function can be promoted through multiple pathways, resulting in a common cell phenotype characterized by the expression of Uncoupling Protein-1 and the ability to dissipate energy, but local and systemic stimuli are necessary to promote adequate thermogenic fat vascularization, which is a precondition for the transport of substrate and the dissipation of heat. Angiopoietin-2 is an important driver of vascularization, and its transcription is in part promoted by estrogen signaling. In this study we demonstrate that adipose tissue-specific knock out of Angiopoietin-2 causes a female-specific reduced thermogenic fat differentiation and function, resulting in obesity and impaired glucose tolerance with end-organ features consistent with metabolic syndrome. In humans, angiopoietin-2 levels are higher in females than in males, and are inversely correlated with adiposity and age more strongly in pre-menopause when compared to post-menopause. Collectively, these data indicate a novel and important role for estrogen-mediated Angiopoietin-2 adipose tissue production in the protection against calorie overload in females, and potentially in the development of postmenopausal weight gain.

Identifiants

pubmed: 36055577
pii: S2212-8778(22)00157-0
doi: 10.1016/j.molmet.2022.101588
pmc: PMC9486017
pii:
doi:

Substances chimiques

Angiopoietin-2 0
Estrogens 0
Uncoupling Protein 1 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

101588

Subventions

Organisme : NIA NIH HHS
ID : P30 AG028747
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL072515
Pays : United States
Organisme : NHLBI NIH HHS
ID : R35 HL155651
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG018728
Pays : United States
Organisme : NIGMS NIH HHS
ID : U01 GM074518
Pays : United States

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier GmbH.. All rights reserved.

Auteurs

Bin Ni (B)

Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, Virginia Commonwealth University School of Medicine, Richmond, VA, USA; Central Virginia VA Health Care System (CVHCS)/McGuire VA Medical Center, Richmond, VA, USA.

Shanshan Chen (S)

Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, Virginia Commonwealth University School of Medicine, Richmond, VA, USA; Department of Biostatistics, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.

Kathleen A Ryan (KA)

Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.

Michael L Maitland (ML)

Section of Hematology/Oncology, Department of Medicine, and Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago Medicine and Biological Sciences, Chicago, IL, USA; Inova Center for Personalized Health, Inova Schar Cancer Institute, Falls Church, VA, USA.

Jared S Farrar (JS)

Center for Clinical and Translational Research, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.

Martin Witzenrath (M)

Charité - Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Berlin, Germany; German Center for Lung Research (DZL), Berlin, Germany.

Birgitt Gubier (B)

Charité - Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Berlin, Germany.

Cindy Serdjebi (C)

Biocellvia, Marseille, France.

Karine Bertotti (K)

Biocellvia, Marseille, France.

Rui Wang (R)

Pauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.

Fadi N Salloum (FN)

Pauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.

Luigi Marino (L)

Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.

Braxton D Mitchell (BD)

Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA; Geriatrics Research and Education Clinical Center, Baltimore Veterans Administration Medical Center, Baltimore, MD, USA.

Francesco S Celi (FS)

Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, Virginia Commonwealth University School of Medicine, Richmond, VA, USA. Electronic address: francesco.celi@vcuhealth.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH